Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatopulmonary Radio-sterilization Combined With Checkpoint Inhibition, a Proof-of-concept Phase II Clinical Trial in Colorectal Cancer

NCT06053996 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT06053996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06053996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatopulmonary Radio-sterilization Combined With Checkpoint Inhibition, a Proof-of-concept Phase II Clinical Trial in Colorectal Cancer
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2023
Completion date
August 30, 2028
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, liver metastasis colon cancer, rectal cancer